labyrinthin peptide vaccine LabVax 3(22)-23

{
  "id": "MLC-T-ONC-014685",
  "term": "labyrinthin peptide vaccine LabVax 3(22)-23",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic peptide vaccine composed of four synthetic peptide epitopes of the tumor-associated antigen (TAA) labyrinthin, with potential immunomodulating and antineoplastic activities. Upon vaccination with labyrinthin peptide vaccine LabVax 3(22)-23, the labyrinthin peptides may stimulate the immune system to mount B-cell and cytotoxic T-lymphocyte (CTL) responses against labryrinthin-expressing tumor cells. Labyrinthin is expressed on the surface of essentially all adenocarcinomas, but is not expressed in normal, healthy cells.",
  "synonyms": [
    "LabVax",
    "LabVax 3(22)-23",
    "labyrinthin-targeting peptide vaccine LabVax 3(22)-23",
    "peptide vaccine LabVax 3(22)-23"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/labyrinthin-peptide-vaccine-labvax-3-22-23/"
}